UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
SCHEDULE 13D
[Rule 13d-101]
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT TO 240.13d-2(a) AND AMENDMENTS THERETO FILED
PURSUANT TO 240.13d-2(a)
(Amendment No. 9)*
 
 
RADA ELECTRONIC INDUSTRIES LTD.
(Name of Issuer)

Ordinary Shares, NIS 0.03 par value
(Title of Class of Securities)

M81863124
(CUSIP Number)
 
Jonathan M. Nathan, Adv.
Meitar LiquoErnik Geva Leshem Tal, Law Offices
16 Abba Hillel Silver Rd.
Ramat-Gan 5250608, Israel
+972-3-610-3100
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
October 24, 2017
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
 
*The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).
 
(Continued on following pages)
 (Page 1 of 9 Pages)
 


  CUSIP No.      M81863124
13D/A
      Page 2 of 9 Pages     
 
1
NAMES OF REPORTING PERSONS:
 
 
 
DBSI Investments Ltd.
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
 
 
(a) ☐
(b) ☒
 
 
 
 
3
SEC Use Only
 
 
 
 
 
 
 
 
4
SOURCE OF FUNDS:
 
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E):
 
 
 
☐
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION:
 
 
 
Israel
 
 
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER:
 
 
 
10,781,634 (1)
 
 
 
 
8
SHARED VOTING POWER:
 
 
 
0
 
 
 
 
9
SOLE DISPOSITIVE POWER:
 
 
 
10,601,634 (1)
 
 
 
 
10
SHARED DISPOSITIVE POWER:
 
 
 
180,000 (2)
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
 
 
 
10,781,634 (1)
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
 
 
 
☐
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
 
 
 
32.9% (3)
 
 
 
 
14
TYPE OF REPORTING PERSON:
 
 
 
CO
 
 
 
 
 
(1)  Includes an aggregate of 1,454,546 ordinary shares issuable upon exercise of warrants held by the Reporting Person. See Item 5.
(2)  Consists of 180,000 ordinary shares that are subject to an option to purchase that was granted by the Reporting Person to another shareholder of the Issuer. See Items 1, 5 and 6.
(3)  Percentage shown is based on 31,345,763 Ordinary Shares outstanding as of October 24, 2017, which is based on information provided to the Reporting Person by the Issuer upon the Reporting Person's inquiry. See Item 5.
 
2 of 9

  CUSIP No.      M81863124
13D/A
      Page 3 of 9      
 
1
NAMES OF REPORTING PERSONS:
 
 
 
Barak Dotan
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
 
 
(a) ☐
(b) ☒
 
 
 
 
3
SEC Use Only
 
 
 
 
 
 
 
 
4
SOURCE OF FUNDS:
 
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E):
 
 
 
☐
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION:
 
 
 
Israel
 
 
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER:
 
 
 
0
 
 
 
 
8
SHARED VOTING POWER:
 
 
 
10,781,634 (1)
 
 
 
 
9
SOLE DISPOSITIVE POWER:
 
 
 
0
 
 
 
 
10
SHARED DISPOSITIVE POWER:
 
 
 
10,781,634 (1) (2)
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
 
 
 
10,781,634 (1)
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
 
 
 
☐
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
 
 
 
32.9% (3)
 
 
 
 
14
TYPE OF REPORTING PERSON:
 
 
 
IN
 
 
 
 
 
(1) Includes an aggregate of 1,454,546 ordinary shares issuable upon exercise of warrants held by DBSI Investments Ltd. ("DBSI"), with respect to which the Reporting Person shares beneficial ownership. See Item 5.
(2) Includes 180,000 ordinary shares held by DBSI that are subject to an option to purchase granted by DBSI to another shareholder of the Issuer. See Items 1, 5 and 6.
(3) Percentage shown is based on 31,345,763 Ordinary Shares outstanding as of October 24, 2017, which is based on information provided to DBSI by the Issuer upon DBSI's inquiry. See Item 5.
 
 
3 of 9
 
  CUSIP No.      M81863124
13D/A
      Page 4 of 9      
 
1
NAMES OF REPORTING PERSONS:
 
 
 
Yossi Ben Shalom
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
 
 
(a) ☐
(b) ☒
 
 
 
 
3
SEC Use Only
 
 
 
 
 
 
 
 
4
SOURCE OF FUNDS:
 
 
 
OO
 
 
 
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E):
 
 
 
☐
 
 
 
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION:
 
 
 
Israel
 
 
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER:
 
 
 
0
 
 
 
 
8
SHARED VOTING POWER:
 
 
 
10,781,634 (1)
 
 
 
 
9
SOLE DISPOSITIVE POWER:
 
 
 
0
 
 
 
 
10
SHARED DISPOSITIVE POWER:
 
 
 
10,781,634 (1) (2)
 
 
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
 
 
 
10,781,634 (1)
 
 
 
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES:
 
 
 
☐
 
 
 
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11):
 
 
 
32.9% (3)
 
 
 
 
14
TYPE OF REPORTING PERSON:
 
 
 
IN
 
 
 
 
 
(1) Includes an aggregate of 1,454,546 ordinary shares issuable upon exercise of warrants held by DBSI, with respect to which the Reporting Person shares beneficial ownership. See Item 5.
(2) Includes 180,000 ordinary shares held by DBSI that are subject to an option to purchase granted by DBSI to another shareholder of the Issuer. See Items 1, 5 and 6.
(3) Percentage shown is based on 31,345,763 Ordinary Shares outstanding as of October 24, 2017, which is based on information provided to DBSI by the Issuer upon DBSI's inquiry. See Item 5.
 
4 of 9
 
Item 1.
Security And Issuer.
 
This Amendment No. 9 (this "Amendment No. 9") to the Statement of Beneficial Ownership on Schedule 13D filed on June 2, 2016 (the "Statement"), as amended by Amendment No. 1 thereto filed on August 29, 2016 ("Amendment No. 1"), Amendment No. 2 thereto filed on November 23, 2016 ("Amendment No. 2"), Amendment No. 3 thereto filed on January 25, 2017 ("Amendment No. 3"), Amendment No. 4 thereto filed on February 6, 2017 ("Amendment No. 4"), Amendment No. 5 thereto filed on February 27, 2017 ("Amendment No. 5"), Amendment No. 6 thereto filed on August 18, 2017 ("Amendment No. 6"), Amendment No. 7 thereto filed on September 6, 2017 ("Amendment No. 7") and Amendment No. 8 thereto filed on September 28, 2017 ("Amendment No. 8"), relates to the Ordinary Shares, NIS 0.03 par value per share ("Ordinary Shares") of RADA Electronic Industries Ltd., an Israeli company (the "Issuer" or "RADA").  Capitalized terms used herein that are not otherwise defined shall have the respective meanings assigned thereto in the Statement and/or in Amendments No. 1, No. 2, No. 3, No. 4, No. 5, No. 6, No. 7 and No. 8.
 
This Amendment No. 9 is being filed by the Reporting Persons to report (i) the sale by DBSI (as defined in Item 2 below), in open market transactions entered into from October 10, 2017 through October 25, 2017, of an additional 1,022,037 Initial Shares, in the aggregate, that had been acquired by it at the Closing, and (ii) the exercise by DBSI, on October 24, 2017, of 1,363,636 Warrants to purchase 1,363,636 Second Warrant Shares at an exercise price of $0.55 per share for an aggregate exercise price of $750,000. The foregoing transactions have increased, in the aggregate, the number of Ordinary Shares actually held by DBSI relative to the number reported in Amendment No. 8 (while decreasing the number of, and the percentage (by greater than 1%) of the outstanding, Ordinary Shares beneficially owned by DBSI and the other Reporting Persons, due to the reduction in the remaining number of Warrants held by DBSI resulting from the above-described exercise of Warrants).
 
Except as modified by the information provided in this Item 1, the information set forth in Item 1 of the Statement, as supplemented by the information that appeared in Item 1 of Amendments No. 1, No. 2, No. 3, No. 4, No. 5, No. 6, No. 7 and No. 8, is incorporated by reference herein in response to the disclosure requirements of Item 1 of Schedule 13D.
 
Item 2.
Identity and Background
 
This Amendment No. 9 is being filed by each of (1) DBSI Investments Ltd. ("DBSI" or the "Reporting Entity"), (2) Barak Dotan and (3) Yossi Ben Shalom.
 
Messrs. Dotan and Ben Shalom are together referred to sometimes hereafter as the “Reporting Individuals”, and, together with the Reporting Entity, the “Reporting Persons”.

The information set forth in the Statement in response to:

·
paragraphs (b)-(c) and (f) of Item 2, concerning DBSI;
·
paragraphs (a), (b), (c) and (f) of Item 2, concerning DBSI’s executive officers and directors;
·
paragraphs (a), (b), (c) and (f) of Item 2, concerning DBSI’s controlling shareholders;
·
paragraphs (b)-(c) and (f) of Item 2, concerning Mr. Barak Dotan; and
·
paragraphs (b)-(c) and (f) of Item 2, concerning Mr. Yossi Ben Shalom
 
is in each case incorporated by reference herein in response to the disclosures required by the corresponding paragraphs of this Amendment No. 9.
 
(d)        Criminal Proceedings: The information set forth in the corresponding paragraph of the Statement (with respect to each of (i) DBSI, its executive officers and directors, and its controlling shareholders, (ii) Mr. Barak Dotan and (iii) Mr. Yossi Ben Shalom) is incorporated by reference herein.
 
(e)        Civil Proceedings: The information set forth in the corresponding paragraph of the Statement (with respect to each of (i) DBSI, its executive officers and directors, and its controlling shareholders, (ii) Mr. Barak Dotan and (iii) Mr. Yossi Ben Shalom) is incorporated by reference herein.
 
Item 3.
Source and Amount of Funds or Other Consideration.
 
The internal funds of DBSI served as the source of funds for the exercise by DBSI of Warrants to purchase 1,363,636 Second Warrant Shares at an exercise price of $0.55 per share for an aggregate exercise price of $750,000, as reported in this Amendment No. 9.
 
 
5 of 9
Item 4.
Purpose of Transaction.
 
The information set forth in the corresponding paragraph of the Statement with respect to DBSI (and, indirectly, the Reporting Individuals) is incorporated by reference herein. In addition, the Reporting Persons note that DBSI may be required to dispose of up to 180,000 Ordinary Shares to Sphera Capital pursuant to exercise(s) by Sphera Capital of the Sphera Capital Option up until January 31, 2018.
 
DBSI reserves the right at any time to change its present intention with respect to any or all of the matters referred to in this Item 4, or to dispose of any or all of the securities of RADA purchased by it.
 
Except as set forth in this Item 4, DBSI has no current plans or proposals which relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D, although DBSI does not rule out the possibility of effecting or seeking to effect any such actions in the future.
 
Item 5.
Interest in Securities of the Issuer.
 
All calculations of beneficial ownership percentage in this Amendment No. 9 are made on the basis of 31,345,763 Ordinary Shares outstanding as of October 24, 2017, which is based on information provided to DBSI by the Issuer upon DBSI's inquiry. 
 
(a)           DBSI is the beneficial owner of 10,781,634 Ordinary Shares of the Issuer, constituting 32.9% of the issued and outstanding Ordinary Shares of the Issuer. Such number of Ordinary Shares consists of the following:
               (i)
2,889,951 remaining Ordinary Shares from among the Initial Shares purchased by DBSI from the Issuer at the Closing;
               (ii)
4,255,319 First Warrant Shares, in the aggregate, issued to DBSI upon exercise of Warrants on August 29, 2016, November 9, 2016, January 18, 2017 and August 17, 2017;
               (iii)
2,181,818 Second Warrant Shares, in the aggregate, issued to DBSI upon exercise of Warrants on September 6, 2017, September 24, 2017 and October 24, 2017; and
               (iv)
1,454,546 additional Second Warrant Shares issuable to DBSI upon exercise of outstanding Warrants held by it.
DBSI possesses sole power to vote all of the foregoing 10,781,634 Ordinary Shares. DBSI possesses sole power to dispose of 10,601,634 Ordinary Shares and shared power to dispose of 180,000 Ordinary Shares. Such shared dispositive power is shared with Sphera Capital due to the grant by DBSI to Sphera Capital of the Sphera Capital Option, which is exercisable by Sphera Capital at its sole discretion and which (if so exercised) would require DBSI to sell to Sphera Capital up to 180,000 Ordinary Shares.  
 
Messrs. Yossi Ben Shalom and Barak Dotan, by virtue of their relationship with and interests in DBSI, may be deemed to control DBSI and consequently share the beneficial ownership of the foregoing 10,781,634 Ordinary Shares of the Issuer beneficially owned by DBSI, including the right to jointly direct the voting of, and disposition of, such shares. Messrs. Yossi Ben Shalom and Barak Dotan also share dispositive power with Sphera Capital with respect to 180,000 of those 10,781,634 Ordinary Shares (due to Sphera Capital's right to exercise the Sphera Capital Option and force DBSI to sell up to 180,000 Ordinary Shares).
 
(b)          The Reporting Persons and the other persons identified in Item 2 possess either sole power or shared power to vote and direct the vote, and sole power or shared power to dispose or to direct the disposition of, the Issuer’s Ordinary Shares as described in paragraph (a) above.
 
 
6 of 9
 
(c)           During the past 60 days, DBSI has effected the transactions with respect to Ordinary Shares described in paragraph (c) of Item 5 of each of Amendment No. 7 and Amendment No. 8, and, in addition, since the filing of Amendment No. 8, has effected the following additional transactions with respect to Ordinary Shares:
 
 
Type of Transaction and Date
  
Quantity of Ordinary Shares Sold/Purchased
    
 
Price Per Share
    
 
Total ($)
  
Sales:
  
October 10, 2017
    
(118,080
)*
  
$
3.54818
    
$
418,969
  
October 11, 2017
    
(119,703
)*
  
$
3.559
    
$
426,023
  
October 12, 2017
    
(245,309
)*
  
$
3.69694
    
$
906,893
  
October 13, 2017
    
(122,584
)*
  
$
3.52846
    
$
432,533
  
October 16, 2017
    
(101,422
)*
  
$
3.55278
    
$
360,330
  
October 17, 2017
    
(128,400
)*
  
$
3.5394
    
$
454,459
  
October 18, 2017
    
(10,395
)*
  
$
3.50409
    
$
36,425
  
October 19, 2017
    
(48,294
)*
  
$
3.50823
    
$
169,426
  
October 20, 2017
    
(64,201
)*
  
$
3.53689
    
$
227,072
  
October 23, 2017
    
(49,554
)*
  
$
3.5305
    
$
174,950
  
October 24, 2017
    
(10,123
)*
  
$
3.50447
    
$
35,476
  
October 25, 2017
    
(3,972
)*
  
$
3.50
    
$
13,902
  
Purchase of Shares vis Exercise of Warrants:
  
October 24, 2017
    
1,363,636
**
  
$
0.55
    
$
750,000
  
 
(*) This was a sale of Initial Shares purchased by DBSI from the Issuer at the Closing.
(**) These are Second Warrant Shares issued upon exercise of Warrants issued to DBSI at the Closing.
  
 
Except as described in this Amendment No. 9, none of the Reporting Persons has effected any transactions in the Ordinary Shares (or other securities of RADA convertible into, or exercisable for, Ordinary Shares) in the past 60 days.
 
(d)     Not applicable.
 
(e)     Not applicable.
 
Item 6.
 Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
 
Registration Rights
 
The description in Item 6 of the Statement of the registration rights granted by the Issuer to DBSI under each of the Purchase Agreement and the Registration Rights Agreement is incorporated by reference in response to this Item 6. Pursuant to those registration rights, as described in Amendment No. 1, the Issuer filed a shelf registration statement on Form F-3 with the SEC on June 15, 2016, for the public resale by DBSI of up to 5,299,655 Initial Shares (which constituted 2,649,828 Ordinary Shares following the Reverse Share Split), which was declared effective by the SEC on June 22, 2016. Also pursuant to those registration rights, on March 27, 2017, the Issuer filed an additional shelf registration statement on Form F-3 with the SEC, for the public resale by DBSI of up to 4,351,568 Ordinary Shares, which was declared effective by the SEC on March 31, 2017. Furthermore, on September 1, 2017, the Issuer filed an additional shelf registration statement on Form F-3 with the SEC, for the public resale by DBSI of up to 3,549,071 additional Ordinary Shares, which was declared effective by the SEC on September 13, 2017.
 
Rights to Acquire Additional Shares

Warrants
 
The description in Item 6 of the Statement of the Warrants issued by the Issuer to DBSI at the Closing is incorporated by reference in response to this Item 6. In addition, as reported in Items 1 and 5(c) of Amendment No. 1, in Items 1 and 5(c) of Amendment No. 2, in Items 1 and 5(c) of Amendment No. 3,  in Items 1 and 5(c) of Amendment No. 6, in Items 1 and 5(c) of Amendment No. 7, and in Items 1 and 5(c) of this Amendment No. 8 since the filing of the Statement— on August 29, 2016, November 9, 2016, January 18, 2017,  August 17, 2017, September 6, 2017, September 24, 2017 and October 24, 2017— DBSI exercised Warrants to purchase 531,915, 2,127,660, 531,915 and 1,063,829 First Warrant Shares and 181,818, 636,364 and 1,363,636 Second Warrant Shares, respectively.
 

7 of 9
 
Sphera Capital Option
 
The description of the Sphera Capital Option set forth in Item 6 of Amendment No. 5 is incorporated by reference in response to this Item 6.
 
Other than as described above in this Item 6, to the best knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 and between such persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, put or calls, guarantors of profit, division of profit or loss or the giving or withholding of proxies.
 
Item 7.
Materials to be Filed as Exhibits.
 
The following exhibits are filed herewith or incorporated by reference herein (as indicated below):
 
Exhibit No.
  
Description
     
1
  
Purchase Agreement, dated as of April 14, 2016, by and between the Issuer and DBSI (incorporated by reference to Exhibit 4.4 to the Issuer’s Annual Report on Form 20-F for the year ended December 31, 2015, filed with the SEC on May 16, 2016 (hereafter, the “Issuer’s 2015 Form 20-F”))
     
2
  
Registration Rights Agreement, dated as of April 14, 2016, by and between the Issuer and DBSI (incorporated by reference to Exhibit 4.5 to the Issuer’s 2015 Form 20-F)
     
3
  
Warrant to Purchase Ordinary Shares of the Issuer, dated April 14, 2016, issued by the Issuer to DBSI (incorporated by reference to Exhibit 4.8 to the Issuer’s 2015 Form 20-F)
     
4
  
English summary of Option to Purchase Ordinary Shares of the Issuer, granted by DBSI to Sphera Capital Ltd. on January 25, 2017 (incorporated by reference to Exhibit 6 to Amendment No. 5)
     
5
  
Joint Filing Agreement pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended*
 
     _____________________
           *Filed herewith.

8 of 9
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated: October 30, 2017
 
DBSI INVESTMENTS LTD.
 
  
/s/ Barak Dotan
Barak Dotan
Director

/s/ Yossi Ben Shalom
Yossi Ben Shalom
Director
 
/s/ Barak Dotan
BARAK DOTAN
 
/s/ Yossi Ben Shalom
YOSSI BEN SHALOM
 
 
 
9 of 9